Christos A. Galanopoulos, MD, MBA, MSc, FACS is a Renown Health Vice President, Co-Director of The Institute for Health Innovation, Health Economist, Chief Clinical Officer for the Renown Institute for Cancer, a practicing Oncologic Surgeon, and founder of the startup software platform “myHalo.”
As the Co-Director of the Renown Institute for Health Innovation, he leads a team of physicians and scientists in developing a first of its kind “Health Determinants Platform” comprised of phenotypic, genomic, socio-economic, behavioral, and environmental data focused on population health challenges.
As a Health Economist educated at the London School of Economics, he has a deep understanding of global healthcare needs and challenges, Health-Tech Assessment, behavioral and pharmaceutical economics, insurance markets, and macro/micro-economic impact of healthcare policy on population health.
To complement the above skillset, He has completed his MBA at the University of Michigan’s Ross School of Business. In 2012, he was awarded the Leadership Program in Health Policy and Management scholarship from the ACS at Brandeis Heller School for Social Policy and Management, and have worked as a Health Policy Scholar for the American College of Surgeons.
Company/Affiliation: Renown Institute for Health Innovation
Twitter: #Genetics, #HealthyNV, and #NewNevada